Human immunodeficiency virus type-1 (HIV-1) genetic diversity and prevalence of antiretroviral drug resistance mutations in treatment-naïve adults in Jos, North Central Nigeria

Autor: Anejo-Okopi, JA, Agbaji, OO, Agaba, PA, Ugoagwu, PO, Were, K, Onywera, H, Owiti, P, Isa, SE, Otecko, N, Okwori, AEJ, Musa, J, Oguche, S, Sagay, AS, Idoko, JA, Nimzing, L, Jatau, ED, Olonitola, OS

Publikováno v: African Journal of Biotechnology; Vol 12, No 17 (2013)

The presence of human immunodeficiency virus (HIV) type-1 diversity has an impact on vaccine efficacy and drug resistance. It is important to know the circulating genetic variants and associated drug-resistance mutations in the context of scale up of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::06cbda32ef1878fc2eb42018d1099964
https://www.ajol.info/index.php/ajb/article/view/129624

Prevalence of recent and long-established HIV-1 infections among adults newly enrolled for HIV care

Autor: Anejo-Okopi, JA, Agaba, PA, Agbaji, OO, Onywera, H, Agaba, EI, Oguche, S, Nimzing, L, Olonitola, SO

Publikováno v: Highland Medical Research Journal; Vol 13, No 2 (2013); 90-93

Background: The ability to differentiate recent human immunodeficiency virus infections (infection within few months) from long-standing (established) infection is valuable for accurate measurement of the changing patterns of HIV transmission and dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::22be3525fecc84baf8a317e4c03480a1
https://www.ajol.info/index.php/hmrj/article/view/109800

High-Risk Behaviour among Hepatitis B Virus-Infected Patients in a Nigerian Tertiary Hospital

Autor: Iroezindu, MO, Daniyam, CA, Isa, ES, Okeke, EN, Agbaji, OO

Publikováno v: Jos Journal of Medicine; Vol 6, No 1 (2012); 8-12

Background: We evaluated the pattern and socio-demographic predictors of high-risk behaviour for hepatitis B virus (HBV) transmission among HBV-infected Nigerian adults in order to provide clues for intensifying HBV prevention and control.Methodology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::29c90cbb0abf623ef6739205fb3e8fdd
https://www.ajol.info/index.php/jjm/article/view/78866

Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.

Autor: Ebonyi AO; Department of Paediatrics, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Okpokwu J; AIDS Prevention Initiative in Nigeria-supported ISO 15189 Laboratory, Jos University Teaching Hospital, Jos, Nigeria., Rawizza H; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Chebu P; APIN Public Health Initiatives, Plot 1551, Apo Resettlement, Apo District, Abuja, FCT, Nigeria., Chaplin B; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Hamel D; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Oguche S; Department of Paediatrics, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agbaji OO; Department of Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Sagay AS; Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Kanki PJ; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Imade GE; AIDS Prevention Initiative in Nigeria-supported ISO 15189 Laboratory, Jos University Teaching Hospital, Jos, Nigeria.; Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 19; Vol. 11 (3), pp. ofae092. Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).

Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria.

Autor: Anejo-Okopi J; Department of Microbiology, University of Jos, Jos, Nigeria.; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria., Okeke E; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Davwar PM; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Onwuamah C; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Onywera H; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.; Research, Innovations, and Academics Unit, Tunacare Services Health Providers Limited, Nairobi, Kenya., Omaiye P; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Duguru M; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Okojokwu OJ; Department of Microbiology, University of Jos, Jos, Nigeria., Ujah OI; Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, Florida, United States., Jonathan B; Department of Family Medicine, Plateau State Specialist Hospital, Jos, Nigeria., George CA; Department of Family Medicine, Bingham University Teaching Hospital, Jos, Nigeria., Crown RS; Department of Medical Microbiology and Parasitology, Bingham University Teaching Hospital, Jos, Nigeria., Yakubu FB; Department of Chemical Pathology, Jos University Teaching Hospital, Jos, Nigeria., Sokei JO; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Okoli LC; Center for Human Virology and Genomics Nigeria Institute of Medical Research, Lagos, Nigeria., Audu O; Department of Epidemiology and Community Health, Benue State University, Makurdi, Nigeria., Inzaule SC; Department of HIV and Global Hepatitis Program, World Health Organization, Geneva, Switzerland., Abah IO; Department of Pharmacology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agaba P; AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria.; Department of Family Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Agbaji OO; Department of Internal Medicine, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Sagay AS; Department of Obstetrics and Gynaecology, University of Jos, Jos University Teaching Hospital, Jos, Nigeria., Hawkins C; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.

Publikováno v: African journal of laboratory medicine [Afr J Lab Med] 2022 Oct 18; Vol. 11 (1), pp. 1677. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).